Gene · 4175
Papers2,153
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 2,153
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation. | J Biol Chem | 2022 | 35032548 | PubTator, text mining | PubMed |
| The role of m6A RNA methylation in cancer metabolism. | Mol Cancer | 2022 | 35022030 | PubTator, text mining | PubMed |
| BIRC2-BIRC3 amplification: a potentially druggable feature of a subset of head and neck cancers in patients with Fanconi anemia. | Sci Rep | 2022 | 34997070 | PubTator, text mining | PubMed |
| SweepCluster: A SNP clustering tool for detecting gene-specific sweeps in prokaryotes. | BMC Bioinformatics | 2022 | 34991447 | PubTator, text mining | PubMed |
| Association of milk intake with hay fever, asthma, and lung function: a Mendelian randomization analysis. | Eur J Epidemiol | 2022 | 34978666 | PubTator, text mining | PubMed |
| Structural mechanism for the selective phosphorylation of DNA-loaded MCM double hexamers by the Dbf4-dependent kinase. | Nat Struct Mol Biol | 2022 | 34963704 | PubTator, text mining | PubMed |
| Reuterin in the healthy gut microbiome suppresses colorectal cancer growth through altering redox balance. | Cancer Cell | 2022 | 34951957 | PubTator, text mining | PubMed |
| Large-scale migration into Britain during the Middle to Late Bronze Age. | Nature | 2022 | 34937049 | PubTator, text mining | PubMed |
| A Deep-Learning Approach for Inference of Selective Sweeps from the Ancestral Recombination Graph. | Mol Biol Evol | 2022 | 34888675 | PubTator, text mining | PubMed |
| The regulation of KSHV lytic reactivation by viral and cellular factors. | Curr Opin Virol | 2022 | 34872030 | PubTator, text mining | PubMed |
| Clinical significance and effect of lncRNA BBOX1-AS1 on the proliferation and migration of lung squamous cell carcinoma. | Oncol Lett | 2022 | 34820016 | PubTator, text mining | PubMed |
| Low Cell Number Proteomic Analysis Using In-Cell Protease Digests Reveals a Robust Signature for Cell Cycle State Classification. | Mol Cell Proteomics | 2022 | 34742921 | PubTator, text mining | PubMed |
| Transcriptome and Exome Analyses of Hepatocellular Carcinoma Reveal Patterns to Predict Cancer Recurrence in Liver Transplant Patients. | Hepatol Commun | 2022 | 34725972 | PubTator, text mining | PubMed |
| Hyperthermia differentially affects specific human stem cells and their differentiated derivatives. | Protein Cell | 2022 | 34719769 | PubTator, text mining | PubMed |
| Differential regulation of miR-21-5p delays wound healing of melanocyte-deprived vitiligo skin by modulating the expression of tumor-suppressors PDCD4 and Maspin. | J Cell Physiol | 2022 | 34687038 | PubTator, text mining | PubMed |
| PopHumanVar: an interactive application for the functional characterization and prioritization of adaptive genomic variants in humans. | Nucleic Acids Res | 2022 | 34664660 | PubTator, text mining | PubMed |
| Detecting Selection in Multiple Populations by Modeling Ancestral Admixture Components. | Mol Biol Evol | 2022 | 34626111 | PubTator, text mining | PubMed |
| Bioinformatics Analysis of the MicroRNA-Metabolic Gene Regulatory Network in Neuropathic Pain and Prediction of Corresponding Potential Therapeutics. | J Mol Neurosci | 2022 | 34580818 | PubTator, text mining | PubMed |
| An overview on tumor treating fields (TTFields) technology as a new potential subsidiary biophysical treatment for COVID-19. | Drug Deliv Transl Res | 2022 | 34542840 | PubTator, text mining | PubMed |
| Biallelic GINS2 variant p.(Arg114Leu) causes Meier-Gorlin syndrome with craniosynostosis. | J Med Genet | 2022 | 34353863 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4175/papers?page=25